Amniotic Fluid Index(Archived)

Archived, for historical reference only

Introduction

Throughout intrauterine development, the fetus exists in a compartment filled with amniotic fluid, allowing free movement.[1] This fluid acts as a protective cushion against potential injuries, helps maintain a stable temperature, and is inhaled and swallowed by the fetus, contributing to normal lung development.[2] Amniotic fluid is a dynamic substance, with its volume and chemical makeup regulated within narrow limits.[3] The amount of amniotic fluid gradually increases until approximately 34 weeks of gestation, after which it slightly decreases until the 40th week and then declines more sharply until the 42nd week.[4]

The volume at any given moment is a function of several interrelated fluid fluxes. In the early stages of pregnancy, the composition of amniotic fluid resembles a complex dialysate derived from maternal serum. As the fetus grows, changes occur in the fluid's composition; notably, sodium concentration and osmolality decrease while urea, creatinine, and uric acid levels increase.[5][6]

Amniotic fluid also contains various steroid and protein hormones.[7][8] Initially, it has little to no particulate matter, but by 16 weeks of gestation, a significant number of cells shed from the amnion, skin, and tracheobronchial tree are present. These cells are crucial for antenatal diagnosis and serve as a source of DNA for karyotype analysis following amniocentesis.[9]

Typically, fetuses do not defecate during pregnancy; however, if under severe stress, they may pass meconium. This material contains bile pigments that can stain the amniotic fluid green, indicating fetal stress.[10] 

The amniotic fluid index is a standardized method used to measure the amount of amniotic fluid during pregnancy.[11][12] This measurement helps evaluate fetal well-being and detect potential complications such as oligohydramnios or polyhydramnios. The amniotic fluid index is typically performed on patients who are at least 24 weeks pregnant with a singleton gestation.[13][14]

Etiology and Epidemiology

Decreased fetal urine output can arise from several causes, which fall into 2 general categories—fetal urinary tract obstruction and decreased urine production by the fetal kidney.[15] Urinary tract obstruction can occur anywhere along the fetal urinary tract and can be catastrophic for the fetus. Decreased urine production by the fetal kidney typically reflects inadequate blood flow to the fetal kidney, caused by the shunting of fetal blood flow away from the kidney to the heart and brain. This mechanism mirrors the cause of oliguria in critically ill adults.[16][17]

Oligohydramnios

When the fetus receives insufficient nutrients and oxygen from the placenta, blood is redirected away from the fetal kidney, decreasing the glomerular filtration rate and reducing urinary output. Therefore, decreased amniotic fluid volume due to decreased urine production by the fetal kidney is a reflection of chronic hypoperfusion of the fetus.[18][19]

Another common cause of oligohydramnios is the rupture of the amniotic membrane, which allows amniotic fluid to leak out of the uterus.[20]

Polyhydramnios

The normal fetus constantly swallows amniotic fluid and urinates to maintain the fluid level. If the fetus is unable to swallow the typical amounts of amniotic fluid, it can lead to polyhydramnios. This condition can occur due to gastrointestinal malformations; fetal neurological issues, such as anencephaly; or mechanical obstruction of the esophagus by other intrathoracic processes.[21]

Increased production of amniotic fluid can occur due to fetal polyuria, often observed in cases of uncontrolled maternal diabetes with persistently elevated maternal blood sugar levels. In these cases, it may be associated with fetal macrosomia. Many cases of polyhydramnios are idiopathic, meaning no definite cause is identified.[22]

Pathophysiology

Oligohydramnios

The amniotic fluid is primarily made up of fetal urine. Low amniotic fluid volume, known as oligohydramnios, typically indicates either decreased fetal urine output or leakage of amniotic fluid from the uterus, which often occurs when the patient's water breaks.[23]

Polyhydramnios

Polyhydramnios, or increased amniotic fluid volume, also has several potential causes, with 2 primary mechanisms—decreased fetal swallowing of amniotic fluid or increased fetal production of amniotic fluid.[21] Polyhydramnios can cause overdistension of the gravid uterus, especially in cases where the fetus is normal size or large for dates. This overdistension increases the patient's risk for preterm contractions, preterm delivery, and premature rupture of membranes, in which the patient's water breaks before the onset of labor. Overdistension of the uterus is also a risk factor for postpartum hemorrhage after delivery.[24][25]

Specimen Requirements and Procedure

The uterus should be divided into 4 quadrants to assess the amniotic fluid index. Each quadrant should be examined systematically. The ultrasound transducer should be held perpendicular to the patient's spine, not perpendicular to the patient's skin, as is performed in most other ultrasounds, and should be maintained in an axial plane (notch to the patient's right). This technique ensures that each fluid pocket is measured in the same plane. The deepest vertical pocket of fluid in each quadrant should be identified and measured, and these 4 measurements should be added together to calculate the total amniotic fluid index.[26] Calipers should be oriented vertically. Color Doppler is typically placed over the pocket of fluid to ensure that the pocket does not contain any segments of the umbilical cord, which may not be visible in B-mode (standard two-dimensional greyscale) imaging. The calipers may not cross over any segments of the umbilical cord or fetal parts.[19][27]

Alternative Measurements of Amniotic Fluid Volume

A single deepest pocket is used in pregnancies less than 24 weeks or with multiple gestations.[28] The technique used to measure a single deepest pocket, also called a maximum vertical pocket, is identical to the measurement of amniotic fluid amounts in the 4 quadrants used to determine an amniotic fluid index. The entire uterus should be examined, and the single deepest vertical pocket of fluid should be identified and measured. A normal single deepest pocket is 2 to 8 cm. A measurement less than 2 cm indicates oligohydramnios, whereas a measurement greater than 8 cm is polyhydramnios.[29][30]

Results, Reporting, and Critical Findings

Biophysical Profile

Amniotic fluid volume is an important component of the fetal biophysical profile, a specialized ultrasound technique used to assess fetal well-being. The biophysical profile has 4 sonographic components, each of which must be observed within 30 minutes of starting the ultrasound:[31][32]

  • Fetal breathing: Continuous movement of the fetal diaphragm for at least 30 seconds)

  • Fetal movement: At least 3 discrete movements of the fetal body or limbs)

  • Fetal tone: At least 1 active extension of a fetal limb with the return to flexion or opening and closing of the fetal hand

  • Amniotic fluid volume: A single deepest pocket of at least 2 cm

If available, a fetal non-stress test, which measures fetal heart rate tracing, is also performed with the biophysical profile for 5 components.[33]

A healthy, term fetus that is not under physiological stress is expected to demonstrate all 4 of these behaviors on ultrasound. Preterm fetuses may not display all of these behaviors. Therefore, the management of pregnancies in which the fetus does not show all 4 behaviors described depends on the gestational age and the specific factors that are abnormal.[34]

Clinical Significance

The normal range of amniotic fluid volume changes with gestational age. The median amniotic fluid index (AFI) is approximately 14 cm between 20 and 35 weeks of gestation. An AFI below 5 cm indicates oligohydramnios, while the 5th percentile cutoff for the second and third trimesters is about 7 cm. Polyhydramnios is generally diagnosed when the AFI exceeds 24 or 25 cm, depending on local guidelines.[1]

Enhancing Healthcare Team Outcomes

Healthcare professionals, including nurse practitioners and other healthcare providers caring for pregnant patients, must have a solid understanding of the amniotic fluid index. This index is an important indicator of fetal well-being and part of the biophysical profile. When there is suspicion of a problem during pregnancy, the patient should be referred to an obstetrician who may order an ultrasound to determine the amniotic fluid index. Persistently low levels of amniotic fluid index during pregnancy may be associated with a birth defect in the fetus.


Details

Author

Megan Lord

Author

Sarah Marino

Editor:

Martha Kole

Updated:

2/6/2025 12:53:32 AM

References


[1]

Dubil EA, Magann EF. Amniotic fluid as a vital sign for fetal wellbeing. Australasian journal of ultrasound in medicine. 2013 May:16(2):62-70. doi: 10.1002/j.2205-0140.2013.tb00167.x. Epub 2015 Dec 31     [PubMed PMID: 28191176]


[2]

Jain L, Eaton DC. Physiology of fetal lung fluid clearance and the effect of labor. Seminars in perinatology. 2006 Feb:30(1):34-43     [PubMed PMID: 16549212]


[3]

Modena AB, Fieni S. Amniotic fluid dynamics. Acta bio-medica : Atenei Parmensis. 2004:75 Suppl 1():11-3     [PubMed PMID: 15301282]


[4]

Hebbar S, Rai L, Adiga P, Guruvare S. Reference ranges of amniotic fluid index in late third trimester of pregnancy: what should the optimal interval between two ultrasound examinations be? Journal of pregnancy. 2015:2015():319204. doi: 10.1155/2015/319204. Epub 2015 Jan 15     [PubMed PMID: 25685558]


[5]

Brace RA, Cheung CY, Anderson DF. Regulation of amniotic fluid volume: insights derived from amniotic fluid volume function curves. American journal of physiology. Regulatory, integrative and comparative physiology. 2018 Oct 1:315(4):R777-R789. doi: 10.1152/ajpregu.00175.2018. Epub 2018 Jul 19     [PubMed PMID: 30024777]

Level 2 (mid-level) evidence

[6]

Ross MG, Idah R. Correlation of maternal plasma volume and composition with amniotic fluid index in normal human pregnancy. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2004 Feb:15(2):104-8     [PubMed PMID: 15209117]


[7]

Florio P, Romero R, Chaiworapongsa T, Kusanovic JP, Torricelli M, Lowry PJ, Petraglia F. Amniotic fluid and umbilical cord plasma corticotropin-releasing factor (CRF), CRF-binding protein, adrenocorticotropin, and cortisol concentrations in intraamniotic infection and inflammation at term. The Journal of clinical endocrinology and metabolism. 2008 Sep:93(9):3604-9. doi: 10.1210/jc.2007-2843. Epub 2008 Jun 17     [PubMed PMID: 18559919]


[8]

Bhatti G, Romero R, Gomez-Lopez N, Chaiworapongsa T, Than NG, Theis KR, Galaz J, Gotsch F, Pique-Regi R, Berry SM, Kavdia M, Tarca AL. The amniotic fluid proteome changes with term labor and informs biomarker discovery in maternal plasma. Scientific reports. 2023 Feb 23:13(1):3136. doi: 10.1038/s41598-023-28157-3. Epub 2023 Feb 23     [PubMed PMID: 36823217]


[9]

Younesi S, Taheri Amin MM, Hantoushzadeh S, Saadati P, Jamali S, Modarressi MH, Savad S, Delshad S, Amidi S, Geranorimi T, Navidpour F, Ghafouri-Fard S. Karyotype analysis of amniotic fluid cells and report of chromosomal abnormalities in 15,401 cases of Iranian women. Scientific reports. 2021 Sep 30:11(1):19402. doi: 10.1038/s41598-021-98928-3. Epub 2021 Sep 30     [PubMed PMID: 34593920]

Level 3 (low-level) evidence

[10]

Gallo DM, Romero R, Bosco M, Gotsch F, Jaiman S, Jung E, Suksai M, Ramón Y Cajal CL, Yoon BH, Chaiworapongsa T. Meconium-stained amniotic fluid. American journal of obstetrics and gynecology. 2023 May:228(5S):S1158-S1178. doi: 10.1016/j.ajog.2022.11.1283. Epub 2023 Apr 1     [PubMed PMID: 37012128]


[11]

Madendag Y, Madendag IC, Sahin E, Aydin E, Sahin ME, Acmaz G. How Well Do the Popular Ultrasonic Techniques Estimate Amniotic Fluid Volume and Diagnose Oligohydramnios, in Fact? Ultrasound quarterly. 2019 Mar:35(1):35-38. doi: 10.1097/RUQ.0000000000000408. Epub     [PubMed PMID: 30601443]


[12]

Cheung CY, Roberts VHJ, Frias AE, Brace RA. Effects of maternal western-style diet on amniotic fluid volume and amnion VEGF profiles in a nonhuman primate model. Physiological reports. 2018 Oct:6(20):e13894. doi: 10.14814/phy2.13894. Epub     [PubMed PMID: 30353684]


[13]

Zhang Y, Yu Y, Chen L, Zhao W, Chu K, Han X. Risk Factors of Intra-Amniotic Infection Related to Induction with Single-Balloon Catheter: A Case-Control Study. Gynecologic and obstetric investigation. 2019:84(2):183-189. doi: 10.1159/000493795. Epub 2018 Oct 17     [PubMed PMID: 30332669]

Level 2 (mid-level) evidence

[14]

Berezowsky A, Ashwal E, Hiersch L, Yogev Y, Aviram A. Transient Isolated Polyhydramnios and Perinatal Outcomes. Ultraschall in der Medizin (Stuttgart, Germany : 1980). 2019 Dec:40(6):749-756. doi: 10.1055/a-0645-1136. Epub 2018 Sep 25     [PubMed PMID: 30253428]


[15]

Krispin E, Berezowsky A, Chen R, Meizner I, Wiznitzer A, Hadar E, Bardin R. Updating the amniotic fluid index nomograms according to perinatal outcome. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2020 Jan:33(1):113-119. doi: 10.1080/14767058.2018.1487936. Epub 2018 Jul 18     [PubMed PMID: 30021504]


[16]

Kehl S. [Single Deepest Vertical Pocket or Amniotic Fluid Index as Evaluation Test for Predicting Adverse Pregnancy Outcome (SAFE trial): A Multicenter, Open-Label, Randomized Controlled Trial]. Zeitschrift fur Geburtshilfe und Neonatologie. 2018 Feb:222(1):28-30. doi: 10.1055/s-0043-124133. Epub 2018 Mar 2     [PubMed PMID: 29499583]

Level 1 (high-level) evidence

[17]

Lee YJ, Kim SC, Joo JK, Lee DH, Kim KH, Lee KS. Amniotic fluid index, single deepest pocket and transvaginal cervical length: Parameter of predictive delivery latency in preterm premature rupture of membranes. Taiwanese journal of obstetrics & gynecology. 2018 Jun:57(3):374-378. doi: 10.1016/j.tjog.2018.04.008. Epub     [PubMed PMID: 29880168]


[18]

Schulz AM, Lauten A, Lehmann T, Proquitté H, Eckoldt F, Weigel F, Mentzel HJ, Schneider U, John-Kroegel U. Amniotic fluid content in children with kidney and urinary tract anomalies determines pre- and postnatal development. Pediatric nephrology (Berlin, Germany). 2023 Nov:38(11):3635-3643. doi: 10.1007/s00467-023-05988-w. Epub 2023 May 23     [PubMed PMID: 37219638]


[19]

Wax JR, Pinette MG. The amniotic fluid index and oligohydramnios: a deeper dive into the shallow end. American journal of obstetrics and gynecology. 2022 Sep:227(3):462-470. doi: 10.1016/j.ajog.2022.04.016. Epub 2022 Apr 20     [PubMed PMID: 35452652]


[20]

Yoon BH, Kim YA, Romero R, Kim JC, Park KH, Kim MH, Park JS. Association of oligohydramnios in women with preterm premature rupture of membranes with an inflammatory response in fetal, amniotic, and maternal compartments. American journal of obstetrics and gynecology. 1999 Oct:181(4):784-8     [PubMed PMID: 10521729]


[21]

Hamza A, Herr D, Solomayer EF, Meyberg-Solomayer G. Polyhydramnios: Causes, Diagnosis and Therapy. Geburtshilfe und Frauenheilkunde. 2013 Dec:73(12):1241-1246     [PubMed PMID: 24771905]


[22]

Bakhsh H, Alenizy H, Alenazi S, Alnasser S, Alanazi N, Alsowinea M, Alharbi L, Alfaifi B. Amniotic fluid disorders and the effects on prenatal outcome: a retrospective cohort study. BMC pregnancy and childbirth. 2021 Jan 22:21(1):75. doi: 10.1186/s12884-021-03549-3. Epub 2021 Jan 22     [PubMed PMID: 33482755]

Level 2 (mid-level) evidence

[23]

Rabie N, Magann E, Steelman S, Ounpraseuth S. Oligohydramnios in complicated and uncomplicated pregnancy: a systematic review and meta-analysis. Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology. 2017 Apr:49(4):442-449. doi: 10.1002/uog.15929. Epub     [PubMed PMID: 27062200]

Level 1 (high-level) evidence

[24]

Mathew M, Saquib S, Rizvi SG. Polyhydramnios. Risk factors and outcome. Saudi medical journal. 2008 Feb:29(2):256-60     [PubMed PMID: 18246237]


[25]

Yefet E, Daniel-Spiegel E. Outcomes From Polyhydramnios With Normal Ultrasound. Pediatrics. 2016 Feb:137(2):e20151948. doi: 10.1542/peds.2015-1948. Epub 2016 Jan 11     [PubMed PMID: 26755694]


[26]

Crellin HB, Singh V. Sonography Evaluation of Amniotic Fluid. StatPearls. 2025 Jan:():     [PubMed PMID: 34033385]


[27]

Morris JM, Thompson K, Smithey J, Gaffney G, Cooke I, Chamberlain P, Hope P, Altman D, MacKenzie IZ. The usefulness of ultrasound assessment of amniotic fluid in predicting adverse outcome in prolonged pregnancy: a prospective blinded observational study. BJOG : an international journal of obstetrics and gynaecology. 2003 Nov:110(11):989-94     [PubMed PMID: 14592583]

Level 2 (mid-level) evidence

[28]

Nabhan AF, Abdelmoula YA. Amniotic fluid index versus single deepest vertical pocket as a screening test for preventing adverse pregnancy outcome. The Cochrane database of systematic reviews. 2008 Jul 16:2008(3):CD006593. doi: 10.1002/14651858.CD006593.pub2. Epub 2008 Jul 16     [PubMed PMID: 18646160]

Level 1 (high-level) evidence

[29]

Mousavi AS, Hashemi N, Kashanian M, Sheikhansari N, Bordbar A, Parashi S. Comparison between maternal and neonatal outcome of PPROM in the cases of amniotic fluid index (AFI) of more and less than 5 cm. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology. 2018 Jul:38(5):611-615. doi: 10.1080/01443615.2017.1394280. Epub 2018 Feb 9     [PubMed PMID: 29426264]

Level 3 (low-level) evidence

[30]

Blitz MJ, Rochelson B, Stork LB, Augustine S, Greenberg M, Sison CP, Vohra N. Effect of Maternal Body Mass Index and Amniotic Fluid Index on the Accuracy of Sonographic Estimation of Fetal Weight in Late Gestation. American journal of perinatology. 2018 Nov:35(13):1235-1240. doi: 10.1055/s-0037-1618588. Epub 2018 Jan 10     [PubMed PMID: 29320802]


[31]

Lalor JG, Fawole B, Alfirevic Z, Devane D. Biophysical profile for fetal assessment in high risk pregnancies. The Cochrane database of systematic reviews. 2008 Jan 23:2008(1):CD000038. doi: 10.1002/14651858.CD000038.pub2. Epub 2008 Jan 23     [PubMed PMID: 18253968]

Level 1 (high-level) evidence

[32]

Magann EF, Isler CM, Chauhan SP, Martin JN Jr. Amniotic fluid volume estimation and the biophysical profile: a confusion of criteria. Obstetrics and gynecology. 2000 Oct:96(4):640-2     [PubMed PMID: 11004374]


[33]

Umana OD, Vadakekut ES, Siccardi MA. Antenatal Fetal Surveillance. StatPearls. 2025 Jan:():     [PubMed PMID: 30725808]


[34]

Wadhwa PD, Entringer S, Buss C, Lu MC. The contribution of maternal stress to preterm birth: issues and considerations. Clinics in perinatology. 2011 Sep:38(3):351-84. doi: 10.1016/j.clp.2011.06.007. Epub     [PubMed PMID: 21890014]